Corrigendum to “The synergy between miR-486–5p and tamoxifen causes profound cell death of tamoxifen-resistant breast cancer cells” [Biomedicine & Pharmacotherapy141 (2021) 111925] - 18/09/25

Behzad Mansoori ^{a, b, c}, Souzan Najafi ^b, Ali Mohammadi ^c, Haleh AsadollahSeraj ^d, Pouria Savadi ^b, Behnaz Mansoori ^e, Afsaneh Nazari ^f, Ahad Mokhtarzadeh ^b, Elmira Roshani ^g, Pascal HG Duijf ^{h, i, j}, William Cho ^{k, ⁎} , Behzad Baradaran ^{b, ⁎}

^a Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran 

^b Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran 

^c Department of Cancer and Inflammation Research, Institute for Molecular Medicine, University of Southern Denmark, Odense, Denmark 

^d Department of Genetic, Faculty of Biology, University of Kharazmi, Karaj, Iran 

^e Department of Molecular Genetics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran 

^f Department of Genetics, Faculty of Basic Sciences, Islamic Azad University, Zanjan Branch, Zanjan, Iran 

^g Department of Biochemistry, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran 

^h Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, Australia 

ⁱ Centre for Data Science, Queensland University of Technology, Brisbane, Australia 

^j University of Queensland Diamantina Institute, The University of Queensland, Translational Research Institute, Brisbane, Australia 

^k Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, China 

^⁎Corresponding authors.

Le texte complet de cet article est disponible en PDF.